Literature DB >> 32401704

Trends in the incidence rate of genitourinary system cancers in Turkey: 2004-2015.

Pakize Yiğit1, Ömer Ataç2, Sabahattin Aydın3.   

Abstract

OBJECTIVE: To analyze age-standardized urological cancer incidence rates in Turkey during the last twelve years based on the available published data (2004-2015).
MATERIAL AND METHODS: Cancer data were obtained from the reports of Turkish Directorate of Public Health Cancer Department for 2004-2015. A trend analysis was conducted using the joinpoint regression analysis to observe the change in the trends over time. The average annual percentage of change, annual percent change, and the corresponding 95% confidence interval were calculated.
RESULTS: Throughout the observed period, cancer incidence rates in men significantly increased by 3.04%, 4.70%, 4.03%, and 2.97% for all the genital organs, kidney, testis, and prostate, respectively. A significant increase of 3.11% and 1.91% was observed for the urinary system organs and bladder, respectively, of women during the same period.
CONCLUSION: The increase in the incidence rate of urinary system cancers was more prominent than that of all cancers types in general. The total incidence rate of urinary system cancers (bladder and kidney) tends to increase more in women than in men. While there was no cancer with decreased incidence during the entire study period, similar decreases in some urogenital cancer types tended to occur during the second trend period.

Entities:  

Year:  2020        PMID: 32401704      PMCID: PMC7219971          DOI: 10.5152/tud.2020.20008

Source DB:  PubMed          Journal:  Turk J Urol        ISSN: 2149-3235


  15 in total

1.  Permutation tests for joinpoint regression with applications to cancer rates.

Authors:  H J Kim; M P Fay; E J Feuer; D N Midthune
Journal:  Stat Med       Date:  2000-02-15       Impact factor: 2.373

2.  International variation in prostate cancer incidence and mortality rates.

Authors:  Melissa M Center; Ahmedin Jemal; Joannie Lortet-Tieulent; Elizabeth Ward; Jacques Ferlay; Otis Brawley; Freddie Bray
Journal:  Eur Urol       Date:  2012-03-08       Impact factor: 20.096

Review 3.  Overdiagnosis in cancer.

Authors:  H Gilbert Welch; William C Black
Journal:  J Natl Cancer Inst       Date:  2010-04-22       Impact factor: 13.506

Review 4.  Global cancer statistics in the year 2000.

Authors:  D M Parkin
Journal:  Lancet Oncol       Date:  2001-09       Impact factor: 41.316

5.  Trends in aggregate cancer incidence rates in relation to screening and possible overdiagnosis: a word of caution.

Authors:  Stephen W Duffy; Dimitrios Michalopoulos; Sofie Sebuødegård; Solveig Hofvind
Journal:  J Med Screen       Date:  2014-01-20       Impact factor: 2.136

6.  Global cancer statistics, 2002.

Authors:  D Max Parkin; Freddie Bray; J Ferlay; Paola Pisani
Journal:  CA Cancer J Clin       Date:  2005 Mar-Apr       Impact factor: 508.702

7.  Estimates of the worldwide incidence of 25 major cancers in 1990.

Authors:  D M Parkin; P Pisani; J Ferlay
Journal:  Int J Cancer       Date:  1999-03-15       Impact factor: 7.396

8.  Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up.

Authors:  Gerald L Andriole; E David Crawford; Robert L Grubb; Saundra S Buys; David Chia; Timothy R Church; Mona N Fouad; Claudine Isaacs; Paul A Kvale; Douglas J Reding; Joel L Weissfeld; Lance A Yokochi; Barbara O'Brien; Lawrence R Ragard; Jonathan D Clapp; Joshua M Rathmell; Thomas L Riley; Ann W Hsing; Grant Izmirlian; Paul F Pinsky; Barnett S Kramer; Anthony B Miller; John K Gohagan; Philip C Prorok
Journal:  J Natl Cancer Inst       Date:  2012-01-06       Impact factor: 13.506

9.  Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up.

Authors:  Fritz H Schröder; Jonas Hugosson; Monique J Roobol; Teuvo L J Tammela; Marco Zappa; Vera Nelen; Maciej Kwiatkowski; Marcos Lujan; Liisa Määttänen; Hans Lilja; Louis J Denis; Franz Recker; Alvaro Paez; Chris H Bangma; Sigrid Carlsson; Donella Puliti; Arnauld Villers; Xavier Rebillard; Matti Hakama; Ulf-Hakan Stenman; Paula Kujala; Kimmo Taari; Gunnar Aus; Andreas Huber; Theo H van der Kwast; Ron H N van Schaik; Harry J de Koning; Sue M Moss; Anssi Auvinen
Journal:  Lancet       Date:  2014-08-06       Impact factor: 79.321

10.  Estimating average annual per cent change in trend analysis.

Authors:  Limin X Clegg; Benjamin F Hankey; Ram Tiwari; Eric J Feuer; Brenda K Edwards
Journal:  Stat Med       Date:  2009-12-20       Impact factor: 2.373

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.